MYDA Advisors’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

MYDA Advisors’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-101,999	Closed	-$77K	–	175
2022 Q3	$77K	Sell	101,999 -27,801	-21%	-$17.6K	0.04%	142
2022 Q2	$10K	Hold	129,800	–	–	﹤0.01%	193
2022 Q1	$26K	Hold	129,800	–	–	0.01%	188
2021 Q4	$77K	Sell	129,800 -200	-0.2%	-$140	0.02%	221
2021 Q3	$87K	Hold	130,000	–	–	0.02%	237
2021 Q2	$144K	Buy	+130,000	New	+$130K	0.04%	250

MYDA Advisors's FLACW Position: Q4 2022 in Review

MYDA Advisors sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 101,999 shares — an estimated $77K sold.

MYDA Advisors first reported a position in FLACW in Q2 2021 and held it in 6 quarters. The position peaked at $144K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

MYDA Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
MYDA Advisors sold 101,999 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $77K.
MYDA Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2021 and held it in 6 quarters.
MYDA Advisors's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $144K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on MYDA Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.